In a patient with hypernatremia (serum sodium 154 mEq/L) who is refusing oral intake, should we restart furosemide (Lasix) and give a slow intravenous D5W infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Restart Lasix and Use D5W with Extreme Caution in This Hypernatremic Patient

In a patient with hypernatremia (sodium 154 mEq/L) refusing oral intake, restarting furosemide (Lasix) is contraindicated and will worsen the hypernatremia; slow D5W infusion is the appropriate treatment, but only after ensuring the patient is not volume overloaded.

Understanding the Clinical Problem

Your patient has hypernatremia (Na 154 mEq/L, normal 135-145 mEq/L) with poor oral intake. This creates a critical decision point because the underlying volume status determines everything:

Key Assessment: Volume Status First

Before any treatment, you must determine if this is:

  • Hypovolemic hypernatremia (most common with poor oral intake): Patient has lost both water and sodium, but relatively more water loss. Signs include dry mucous membranes, decreased skin turgor, orthostatic hypotension, low urine output.

  • Hypervolemic hypernatremia (less common): Patient has excess total body sodium and water, but sodium excess predominates. Signs include edema, ascites, elevated JVP, pulmonary congestion.

  • Euvolemic hypernatremia: Pure water deficit without significant volume changes.

Why Lasix is Dangerous Here

Furosemide will make hypernatremia worse 1. Loop diuretics cause proportionally more water loss than sodium loss, which increases serum sodium concentration 2, 3. The FDA label for IV furosemide explicitly warns about electrolyte depletion and requires frequent monitoring of serum sodium 1.

Recent research confirms that furosemide without adequate free water replacement worsens hypernatremia—one study showed plasma sodium rising to 150 mmol/L with furosemide alone versus falling to 134 mmol/L when combined with free water 3.

The Only Exception

Furosemide combined with D5W can theoretically work in hypervolemic hypernatremia (volume overload with high sodium), but this requires:

  • Documented volume overload (edema, elevated JVP, pulmonary congestion)
  • Careful calculation of free water needs
  • Intensive monitoring every 2-4 hours
  • The negative sodium/potassium balance must exceed negative water balance 2

This is a specialized approach requiring ICU-level monitoring and is not appropriate for routine management 4.

The Correct Approach: D5W Infusion

For Hypovolemic or Euvolemic Hypernatremia (Most Likely Scenario)

D5W is the appropriate initial treatment 5, 6:

  1. Calculate the water deficit:

    • Water deficit (L) = 0.6 × body weight (kg) × [(current Na/140) - 1]
    • For a 70 kg patient with Na 154: 0.6 × 70 × [(154/140) - 1] = 4.2 L deficit
  2. Determine correction rate:

    • Chronic hypernatremia (>48 hours): Correct slowly at 0.5 mmol/L per hour, maximum 8-10 mmol/L per 24 hours to prevent cerebral edema 5, 6
    • Acute hypernatremia (<48 hours): Can correct faster at 1 mmol/L per hour, but still monitor closely 5
    • Given poor oral intake, this is likely chronic—use slow correction
  3. D5W infusion rate:

    • To decrease Na by 8 mmol/L in 24 hours: approximately 150-200 mL/hour D5W
    • Check sodium every 4-6 hours initially, then every 6-8 hours 6
    • Adjust rate based on response
  4. Monitor for complications:

    • Overcorrection (cerebral edema if too fast in chronic cases)
    • Undercorrection (persistent neurologic symptoms)
    • Volume overload (rare with D5W alone)

Critical Monitoring Parameters

  • Serum sodium every 4-6 hours initially 1
  • Urine output (should increase with adequate hydration)
  • Mental status (improvement indicates adequate correction)
  • Volume status (JVP, lung exam, peripheral edema)
  • Serum osmolality if available

Common Pitfalls to Avoid

  1. Do not use normal saline (0.9% NaCl): Contains 154 mmol/L sodium—same as patient's serum level—will not correct hypernatremia

  2. Do not add furosemide "to help with fluid balance": This reflexive response from heart failure management is dangerous in hypernatremia 4

  3. Do not correct too rapidly in chronic hypernatremia: Risk of cerebral edema from rapid osmotic shifts 5, 6

  4. Do not ignore the underlying cause: Address why the patient is refusing oral intake (dysphagia, delirium, nausea, etc.)

Special Considerations

If Patient Has Heart Failure or Volume Overload

Only if there is documented hypervolemic hypernatremia with signs of volume overload:

  • Consider nephrology consultation for complex fluid management 7, 8
  • May require combination of D5W + furosemide with precise calculations 2
  • Requires ICU-level monitoring with hourly assessments 7
  • Alternative: ultrafiltration in refractory cases 4, 7

Addressing Oral Intake Refusal

Simultaneously work on:

  • Speech/swallow evaluation if dysphagia suspected
  • Treat underlying causes (nausea, delirium, depression)
  • Consider NG tube for enteral free water if IV access limited
  • Involve palliative care if goals of care discussions needed

Practical Algorithm

  1. Assess volume status (exam, vital signs, urine output)
  2. If hypovolemic/euvolemic (most likely): Start D5W at 150-200 mL/hour
  3. If hypervolemic: Consult nephrology before adding furosemide
  4. Check Na every 4-6 hours, adjust D5W rate to achieve 0.5 mmol/L/hour decrease
  5. Address oral intake refusal simultaneously
  6. Transition to oral free water or hypotonic fluids once patient can tolerate

The evidence strongly supports D5W as first-line treatment for hypernatremia with poor oral intake, while furosemide is contraindicated unless there is documented volume overload requiring specialized management 1, 2, 3, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.